Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) ...
Rare-disease families can now invest in Mahzi Therapeutics' gene therapy, giving patients a financial stake in developing ...
The nano-complex is constructed by the sequential mixing of AAV9, TA, and polymers in an aqueous solution. The nano-complexes released the loaded-AAV intracellularly and exhibited efficient gene ...
Gene therapy is a revolutionary field in modern medicine, offering transformative potential to treat and potentially cure a wide range of genetic and acquired diseases. By addressing the root cause of ...
A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's Research Hospital and University College London ...
News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, with a personalized CRISPR gene-editing therapy. The treatment corrects an ...
Back in January 2014, Digital Journal reported that, following a gene therapy trial, patients who were progressing toward blindness had considerably better vision after completing the treatment. The ...
The Well News on MSN
FDA approves first gene therapy technology to treat children with sickle cell disease
WASHINGTON - The Food and Drug Administration Wednesday granted supplemental approval for a breakthrough CRISPR gene therapy medication, making it the first available to treat young children with ...
A team of doctors and scientists have successfully treated a rare genetic condition with the first-ever personalized gene-editing therapy. Results of the groundbreaking treatment have been published ...
Building a quality system for a cell and gene therapy (CGT) product requires a solid foundation based on knowledgeable staff, well-defined roles and decision-making, data integrity, independence of ...
A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's Research Hospital and University College London ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results